VB
VST BIO Corp
SEC filingPharmaceuticals · San Diego, CA
Amount raised$31.9Msold at filing
Total offering$31.9M
Investors in the raise1count reported to the SEC
FiledApr 24, 2026first sale Nov 5, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David ChereshDirector
Rebecque LabaExecutive Officer
William Anthony SessaDirector
J. Anthony WareDirector
Chris Anthony SomervilleDirector
Krisztina ZseboExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.